re: Ann: New CDC Guidelines for use of IGRA (...
You are right Grizzly, this announcement is great news for Cellestis and future QFT sales. However the CDC release has long been anticipated and the content of the guidelines was well known long ago so it is not surprising that the market had already priced it in.
The full year results in August might be surprising IMHO, but the results for FY11 should now be outstanding.
Good to see so much new info appearing on the Cellestis web page so quickly after the CDC guidelines were released - the company is well and truly on the ball.
CST Price at posting:
$2.79 Sentiment: Buy Disclosure: Held